Cationic lipid-DNA complexes for non-viral gene therapy: Relating supramolecular structures to cellular pathways

Expert Opinion on Biological Therapy

Volumn 5, Issue 1, 2005, Pages 33-53

  Ewert, Kai K ^b   Ahmad, Ayesha ^b   Evans, Heather M ^b   Safinya, Cyrus R ^a  

^a University of California   (United States)

^b NONE

Author keywords

Cationic liposomes; Gene delivery; Gene therapy; Lipofection; Multivalent; Non viral; Small angle X ray scattering

Indexed keywords

CATIONIC LIPOSOME; DNA; LIPID; LIPOSOME; MACROGOL; UNCLASSIFIED DRUG;

CELL TRANSPORT; COMPLEX FORMATION; DENSITY; DNA BINDING; ENDOSOME; GENE TRANSFER; GENETIC TRANSFECTION; IN VIVO STUDY; LIPID ANALYSIS; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; REVIEW; STRUCTURE ANALYSIS; SUPRAMOLECULAR CHEMISTRY; SURFACE CHARGE; SURFACE PROPERTY; VIRUS MORPHOLOGY;

CATIONS; CELL MEMBRANE; CLINICAL TRIALS; DNA; GENE THERAPY; HUMANS; LIPIDS; MACROMOLECULAR SUBSTANCES; SIGNAL TRANSDUCTION;

EID: 12244265493     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.5.1.33     Document Type: Review

References (89)

1. Pharmaceutical Perspectives of Nucleic Acid-Based Therapeutics. Mahato RI, Kim SW (Eds), Taylor & Francis, London, UK (2002). The most recent monograph containing contributions on non-viral gene delivery.
2. Non-Viral Vectors for Gene Therapy. Huang L, Hung M-C, Wagner E (Eds), Academic Press, San Diego, USA (1999). A comprehensive monograph on non-viral gene vectors. A second edition is in preparation.
3. See the recent reviews in Curr. Med. Chem. (2004) 11:133-220. A series of reviews on structure, function and theory of lipid-based gene vectors.
4. For another series of recent reviews see Curr. Med. Chem. (2003) 10:1185-1315. A series of reviews primarily on the chemical aspects of lipid-based gene vectors.
5. FELGNER PL, RHODES G: Gene therapeutics. Nature (1991) 349:351-352. A historical overview of non-viral methods.
6. HENRY CM: Gene delivery -without viruses. Chem. Eng. News (2001) 79:35-41.
7. FERBER D: Gene therapy: safer and virus-free? Science (2001) 294:1638-1642.
8. NIIDOME T, HUANG L: Gene therapy progress and prospects: Nonviral vectors. Gene Ther. (2002) 9:1647-1652. A recent critical review of non-viral methods with a therapeutic outlook.
9. CHESNOY S, HUANG L: Structure and function of lipid-DNA complexes for gene delivery. Ann. Rev. Biophys. Biomol. Struct. (2000) 29:27-47. A comprehensive review on synthetic gene delivery systems, including clinical and corporate work.
10. FRIEDMANN T: Overcoming the obstacles to gene therapy. Sci. Am. (1997) 276:96-101.
11. CLARK PR, HERSH EM: Cationic lipid-mediated gene transfer: current concepts. Curr. Opin. Mol. Ther. (1999) 1:158-176. A review of human clinical trials applying lipid vectors.
12. MILLER AD: Cationic liposomes for gene therapy. Angew. Chem. Int. Ed. (1998) 37:1768-1785. A thorough and comprehensive review of the chemistry of earlier lipid systems.
13. FELGNER PL, GADEK TR, HOLM M et al.: Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA (1987) 84:7413-7417. The paper that introduced lipofection.
14. Gene Therapeutics: Methods and Applications of Direct Gene Transfer. Wolff JA (Ed.), Birkhäuser, Boston, USA (1994).
15. NABEL G, NABEL E, YANG Z et al.: Direct gene transfer with dna-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc. Natl. Acad. Sci. USA (1993) 90:11307-11311.
16. EDELSTEIN ML, ABEDI MR, WIXON J, EDELSTEIN RM: Gene therapy clinical trials worldwide 1989-2004 - an overview. J. Gene Med. (2004) 6:597-602. A thorough overview of the available data on gene therapy clinical trials.
17. RAPER SE, CHIRMULE N, LEE FS et al.: Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab. (2003) 80:148-158.
18. CAVAZZANA-CALVO M, HACEIN-BEY S, DE SAINT BASILE G et al.: Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease Science (2000) 288:669-672.
19. HACEIN-BEY-ABINA S, VON KALLE C, SCHMIDT M et al.: A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. (2003) 348:255-256.
20. HACEIN-BEY-ABINA S, VON KALLE C, SCHMIDT M et al.: LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science (2003) 302:415-419.
21. RÄDLER JO, KOLTOVER I, SALDITT T, SAFINYA CR: Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science (1997) 275:810-814. The first description of the lamellar phase of CL-DNA complexes.
22. KOLTOVER I, SALDITT T, RÄDLER JO, SAFINYA CR: An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA Release and delivery. Science (1998) 281:78-81. The first description of the inverted hexagonal phase of CL-DNA complexes.
23. LASIC DD, STREY H, STUART MC, PODGORNIK R, FREDERIK PM: The structure of DNA-liposome complexes. J. Am. Chem. Soc. (1997) 119:832-833.
24. HARRINGTON JJ, VAN BOKKELEN G, MAYS RW, GUSTASHAW K, WILLIARD HF: Formation of de novo centromeres and construction of first-generation human artificial microchromosomes. Nat. Genet. (1997) 15:345-355.
25. WILLARD HF: Genomics and gene therapy: artificial chromosomes coming to life. Science (2000) 290:1308-1309.
26. MILLER AD: The problem with cationic liposome/micelle-based non-viral vector systems for gene therapy. Curr. Med. Chem. (2003) 10:1195-1211. A recent review with a focus on newer platform technologies for the future.
27. KOLTOVER I, SALDITT T, SAFINYA CR: Phase diagram, stability and overcharging of lamellar cationic lipid - DNA self assembled complexes. Biophys. J. (1999) 77:915-924.
28. SALDITT T, KOLTOVER I, RÄDLER JO, SAFINYA CR: Two-dimensional smectic ordering of linear DNA chains in self-assembled DNA-cationic liposome mixtures. Phys. Rev. Lett. (1997) 79:2582-2585.
29. SAFINYA CR: Structures of lipid-DNA complexes: supramolecular assembly and gene delivery. Curr. Opin. Struct. Biol. (2001) 11:440-448.
30. KOLTOVER I, WAGNER K, SAFINYA CR: DNA condensation in two-dimensions. Proc. Natl. Acad. Sci. USA (2000) 97:14046-14052.
31. LIN AJ, SLACK NL, AHMAD A, GEORGE CX, SAMUEL CE, SAFINYA CR: Three-dimensional imaging of lipid gene-carriers: membrane charge density controls universal transfection behavior in lamellar cationic liposome-DNA complexes. Biophys. J. (2003) 84:3307-3316. The original publication on the relevance of membrane charge density and the activated fusion model for lamellar complexes.
32. LIN AJ, SLACK NL, AHMAD A et al.: Structure-function studies of lipid-DNA nonviral gene delivery systems. J. Drug Targeting (2000) 8:13-27.
33. EWERT K, AHMAD A, EVANS HM, SCHMIDT HW, SAFINYA CR: Efficient synthesis and cell-transfection properties of a new multivalent cationic lipid for nonviral gene delivery. J. Med. Chem. (2002) 45:5023-5029.
34. SAFINYA CR, SLACK N, LIN A, KOLTOVER I: Cationic lipid-DNA complexes for gene delivery: structure-function correlations. In: Pharmaceutical Perspectives of Nucleic Acid-Based Therapeutics. Mahato RI, Kim SW (Eds), Taylor & Francis, London, UK (2002):190-209.
35. SAFINYA CR, KOLTOVER I: Self assembled strutures of lipid-dna nonviral gene delivery systems from synchrotron x-ray diffraction. In: Non-Viral Vectors for Gene Therapy. Huang L, Hung M-C, Wagner E (Eds), Academic Press, San Diego, USA (1999):92-117.
36. RINEHART J, HERSH E, ISSELL B, TRIOZZI P, BUHLES W, NEIDHART J: Phase I trial of recombinant human interleukin-1-beta (rhIL-1-beta), carboplatin, and etoposide in patients with solid cancers: Southwest Oncology Group Study 8940. Cancer Invest. (1997) 15:403-410.
37. STOPECK AT, HERSH EM, BRAILEY JL, CLARK PR, NORMAN J, PARKER SE: Transfection of primary tumor cells and tumor cell lines with plasmid DNA/lipid complexes. Cancer Gene Ther. (1998) 5:119-126.
38. MANNING GS: Limiting laws and counterion condensation in polyelectrolyte solutions. I. Colligative properties. J. Chem. Phys. (1978) 51:924-933.
39. LE BRET M, ZIMM BH: Distribution of counterions around a cylindrical polyelectrolyte and Manning's condensation theory. Biopolymers (1984) 23:287-312.
40. HARRIES D, MAY S, GELBART WM, BEN-SHAUL A: Structure, stability, and thermodynamics of lamellar DNA-lipid complexes. Biophys. J. (1998) 75:159-173.
41. MAY S, BEN-SHAUL A: Modeling of cationic lipid-DNA complexes. Curr. Med. Chem. (2004) 11:151-167. A recent review of theoretical work on CL-DNA complexes.
42. MISLICK KA, BALDESCHWIELER JD: Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc. Natl. Acad. Sci. USA (1996) 93:12349-12354.
43. MOUNKES LC, ZHONG W, CIPRESPALACIN G, HEATH TD, DEBS RJ: Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo. J. Biol. Chem. (1998) 273:26164-26170.
44. KOPATZ I, REMY J-S, BEHR J-P: A model for non-viral gene delivery: through syndecan adhesion molecules and powered by actin. J. Gene Med. (2004) 6:769-776.
45. BRUINSMA R: Electrostatics of DNA cationic lipid complexes: isoelectric instability. Eur. Phys. J. B (1998) 4:75-88.
46. ISRAELACHVILI JN: Intermolecular and Surface Forces. Israelachvili JN (Ed.), Academic Press, London, UK (1992).
47. BLOOMFIELD VA: Condensation of DNA by multivalent cations: considerations on mechanism. Biopolymers (1991) 31:1471-1481.
48. TRANCHANT I, THOMPSON B, NICOLAZZI C, MIGNET N, SCHERMAN D: Physicochemical optimization of plasmid delivery by cationic lipids. J. Gene Med. (2004) 6:S24-S35. A good and recent review emphasising properties of lipid gene vectors beyond their chemical structure.
49. WIETHOFF CM, MIDDAUGH CR: Barriers to nonviral gene delivery. J. Pharm. Sci. (2003) 92:203-217.
50. FARHOOD H, SERBINA N, HUANG L: The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim. Biophys. Acta (1995) 1235:289-295.
51. HUI S, LANGNER M, ZHAO Y, ROSS P, HURLEY E, CHAN K: The role of helper lipids in cationic liposome-mediated gene transfer. Biophys. J. (1996) 71:590-599.
52. GRUNER SM, TATE MW, KIRK GL et al.: X-ray-diffraction study of the polymorphic behavior of N-methylated dioleoylphosphatidylethanolamine. Biochemistry (1988) 27:2853-2866.
53. TRISTRAM-NAGLE S, PETRACHE HI, NAGLE JF: Structure and interactions of fully hydrated dioleoylphosphatidylcholine bilayers. Biophys. J. (1998) 75:917-925.
54. WROBEL I, COLLINS D: Fusion of cationic liposomes with mammalian cells occurs after endocytosis. Biochim. Biophys. Acta (1995) 1235:296-304.
55. FELGNER PL: Particulate systems and polymers for in vitro and in vivo delivery of polynucleotides. Adv. Drug Deliv. Rev. (1990) 5:163-187.
56. SCHULZE U, SCHMIDT HW, SAFINYA CR: Synthesis of novel cationic poly(ethylene glycol) containing lipids. Bioconjug. Chem. (1999) 10:548-552.
57. EWERT K, SLACK NL, AHMAD A et al.: Cationic lipid-DNA complexes for gene therapy: understanding the relationship between complex structure and gene delivery pathways at the molecular level. Curr. Med. Chem. (2004) 11:133-149.
58. AHMAD A, EVANS H, EWERT K, GEORGE CX, SAMUEL CE, SAFINYA CR: New multivalent lipids reveal bell curve for transfection efficiency versus membrane charge density: nonviral lipid-DNA complexes for gene delivery. J. Gene Med. (2005) (In Press).
59. SEDDON JM: Structure of the inverted hexagonal (HII) phase, and non-lamellar phase transitions of lipids. Biochim. Biophys. Acta (1990) 1031:1-69.
60. JANIAK MJ, SMALL DM, SHIPLEY GG: Temperature and compositional dependence of the structure of hydrated dimyristoyl lecithin. J. Biol. Chem. (1979) 254:6068-6078.
61. GOMPPER G, GOOS J: Fluctuations and phase behavior of passages in a stack of fluid membranes. J. Phys. II (France) (1995) 5:621-634.
62. PLANK C, MECHTLER K, SZOKA FC, WAGNER E: Activation of the complement system by synthetic dna complexes: a potential barrier for intravenous gene delivery. Hum. Gene Ther. (1996) 7:1437-1446. An important paper on obstacles to gene delivery in vivo and a possible way to overcome them.
63. LASIC DD, PAPAHADJOPOULOS D: Liposomes Revisited. Science (1995) 267:1275-1276.
64. BRADLEY AJ, DEVINE DV, ANSELL SM, JANZEN J, BROOKS DE: Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol) lipids. Arch. Biochem. Biophys. (1998) 357:185-194.
65. Stealth Liposomes. Lasic DD, Martin FJ (Eds), CRC Press, Boca Raton, FL, USA (1995).
66. WOODLE MC: Sterically stabilized liposome therapeutics. Adv. Drug Deliv. Rev. (1995) 16:249-265.
67. MARTIN-HERRANZ A, AHMAD A, EVANS HM et al.: Surface functionalized cationic lipid-DNA complexes for gene delivery: PEGylated lamellar complexes exhibit distinct DNA-DNA interaction regimes. Biophys. J. (2004) 86:1160. A thorough study of the effect of incorporating PEG-lipids into CL-DNA complexes.
68. SALDITT T, KOLTOVER I, RÄDLER O, SAFINYA CR: Self-assembled DNA-cationic-lipid complexes: two-dimensional smectic ordering, correlations, and interactions. Phys. Rev. E (1998) 58:889-904.
69. VASILEVSKAYA VV, KHOKHLOV AR, MATSUZAWA Y, YOSHIKAWA K: Collapse of single DNA molecule in poly(ethylene glycol) solutions. J. Chem. Phys. (1995) 102:6595-6602.
70. DEVANAND K, SELSER JC: Asymptotic-behavior and long-range interactions in aqueous-solutions of poly(ethylene oxide). Macromolecules (1991) 24:5943-5947.
71. WARRINER HE, IDZIAK SH, SLACK NL, DAVIDSON P, SAFINYA CR: Lamellar biogels: Fluid-membrane-based hydrogels containing polymer lipids. Science (1996) 271:969-973.
72. HARVIE P, WONG FM, BALLY MB: Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid-DNA particles. J. Pharm. Sci. (2000) 89:652-663.
73. PITARD B, OUDRHIRI N, LAMBERT O et al.: Sterically stabilized BGTC-based lipoplexes: structural features and gene transfection into the mouse airways in vivo. J. Gene Med. (2001) 3:478-487.
74. WHEELER JJ, PALMER L, OSSANLOU M et al.: Stabilized plasmid-lipid particles: construction and characterization. Gene Ther. (1999) 6:271-281. An alternative method of preparing lipid-DNA assemblies, resulting in well defined, sterically stabilised particles.
75. ALLEN TM: Long-circulating (sterically stabilized) liposomes for targeted drug-delivery. Trends Pharmacol. Sci. (1994) 15:215-220.
76. DALKARA D, ZUBER G, BEHR J-P: Intracytoplasmatic delivery of anionic proteins. Mol. Ther. (2004) 9:964-969.
77. SUBRAMANIAN G, HJELM RP, DEMING TJ, SMITH GS, LI Y, SAFINYA CR: Structure of complexes of cationic lipids and poly(glutamic acid) polypeptides: a pinched lamellar phase. J. Am. Chem. Soc. (2000) 122:26-34.
78. WONG GC, TANG JX, LIN A, LI Y, JANMEY PA, SAFINYA CR: Hierarchical self-assembly of f-actin and cationic lipid complexes: stacked three-layer tubule networks. Science (2000) 288:2035-2039.
79. SUH W, HAN SO, YU L, KIM SW: An angiogenic, endothelial-cell-targeted polymeric gene carrier. Mol. Ther. (2002) 6:664-672.
80. WOODLE MC, SCARIA P, GANESH S et al.: Sterically stabilized polyplex: ligand-mediated activity. J. Control. Release (2001) 74:309-311.
81. MIDOUX P, PICHON C: Peptide-based gene delivery systems. In: Pharmaceutical Perspectives of Nucleic Acid-Based Therapeutics. Mahato RI, SW Kim (Eds), Taylor & Francis, London, UK (2002):334-366.
82. KALDERON D, ROBERTS BL, RICHARDSON WD, SMITH AE: A short amino acid sequence able to specify nuclear localization. Cell (1984) 39:499-509.
83. JANS DA, CHAN CK, HÜBNER S: Signals mediating nuclear targeting and their regulation: application in drug delivery. Med. Res. Rev. (1998) 18:189-223.
84. MORTIMER I, TAM P, MACLACHLAN I, GRAHAM RW, SARAVOLAC EG, JOSHI PB: Cationic lipid-mediated transfection of cells in culture requires mitotic activity. Gene Ther. (1999) 6:403-411.
85. CARTIER R, RESZKA R: Utilization of synthetic peptides containing nuclear localization signals for nonviral gene transfer systems. Gene Ther. (2002) 9:157-167. A good, critical review of work that employed NLS peptides for non-viral vectors.
86. ESCRIOU V, CARRIERE M, SCHERMAN D, WILS P: NLS bioconjugates for targeting therapeutic genes to the nucleus. Adv. Drug Deliv. Rev. (2003) 55:295-306. Another, slightly more recent, critical review of work employing NLS peptides.
87. HEBERT E: Improvement of exogenous DNA nuclear importation by nuclear localization signal-bearing vectors: a promising way for non-viral gene therapy? Biol. Cell (2003) 95:59-68.
88. SAFINYA CR, SIROTA EB, ROUX D, SMITH GS: Universality in interacting membranes: the effect of cosurfactants on the interfacial rigidity. Phys. Rev. Lett. (1989) 62:1134-1137.
89. SZLEIFER I, BEN-SHAUL A, GELBART WM: Chain packing statistics and thermodynamics of amphilphile monolayers. J. Phys. Chem. (1990) 94:5081-5089.